Epidermal growth factor receptor-mediated selective cytotoxicity of antitumor agents toward human xenografts and murine syngeneic solid tumors

Japanese Journal of Cancer Research : Gann
H AmagaseS Tsukagoshi

Abstract

Severe toxic side effects of antiproliferative agents limit their clinical usefulness as antitumor drugs. Recently we observed that the antitumor efficacy of various antitumor agents (5-fluorouracil, tegafur, adriamycin, mitomycin C, cyclophosphamide, and cisplatin) against experimental solid tumors was enhanced by prior or simultaneous administration of human epidermal growth factor (EGF). However, coadministration of EGF did not enhance the toxicity of antitumor agents as measured by LD50 and body weight loss. The above selective potentiation of efficacy of the antitumor agents by human EGF can be characterized as follows. In a dose-dependent manner, human EGF enhanced the efficacy of an antitumor agent (5-FU) treatment against human epidermoid carcinoma A431 transplanted sc in athymic nude mice [ED50 = 2.9 (0.2-49.7, 95% confidence interval) microgram/kg, sc]. Various degrees of enhancement were also observed against other experimental tumors transplanted sc. The degrees of enhancement were directly proportional to the numbers of human EGF binding sites present on tumor cell plasma membrane (threshold of binding site density = 1.5 X 10(3) sites/cell) using 5-FU or cisplatin as an antitumor agent, thus suggesting that the bin...Continue Reading

References

Jan 1, 1976·Experientia·S P RoseH Herschman
Nov 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E Rozengurt, L A Heppel
Jan 1, 1987·Journal of Pediatric Gastroenterology and Nutrition·N Gallo-PayetJ S Hugon
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T OkaT Miyake
Sep 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·H A Armelin
Oct 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·M D Hollenberg, P Cuatrecasas
Jan 1, 1984·International Journal of Radiation Oncology, Biology, Physics·E CaceresG Zubrod

❮ Previous
Next ❯

Citations

Jun 1, 1994·Cancer Metastasis Reviews·R D ChristenS B Howell
Jan 1, 1990·Journal of Cancer Research and Clinical Oncology·E Tahara
Dec 1, 1991·Pharmacology & Therapeutics·K J ScanlonT Funato
Jan 1, 1991·Pharmacology & Therapeutics·T R Tritton
Aug 19, 1991·International Journal of Cancer. Journal International Du Cancer·T T Kwok, R M Sutherland
May 1, 1990·Japanese Journal of Cancer Research : Gann·H AmagaseS Tsukagoshi
Aug 15, 1994·International Journal of Cancer. Journal International Du Cancer·A Basu, R W Evans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.